Effect of Varying the Protein and Dietary Fiber Content of Energy Bars on Their Glycemic and Insulinemic Impact

NCT02537587 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2015-09-01

No results posted yet for this study

Summary

The purpose of this study was to determine the effect of changing the amounts of resistant starch, whey protein and sugar on the blood glucose and insulin responses elicited by energy bars. The investigators also compared the glucose and insulin responses to the rates at which the food bars were digested in-vitro (in the test tube). The investigators thought increasing resistant starch and reducing sugar would reduce the glucose and insulin responses, and that adding protein would reduce glucose and increase insulin. The investigators also thought the glucose and insulin responses in people would be related to the rate of digestion of the food bars in-vitro.

Conditions

Interventions

OTHER

Control 1

67g of control bar

OTHER

Control 2

86g of control bar

OTHER

15/0

66g of experimental bar 15/0

OTHER

15/0LS

84g of experimental bar 15/0LS

OTHER

15/5

75g of experimental bar 15/5

OTHER

10/5

72g of experimental bar 10/5

OTHER

10/10

80g of experimental bar 10/10

Sponsors & Collaborators

  • PepsiCo Global R&D

    collaborator INDUSTRY
  • Glycemic Index Laboratories, Inc

    lead INDUSTRY

Principal Investigators

  • Thomas MS Wolever, MD, PhD · Glycemic Index Laboratories, Inc

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02537587 on ClinicalTrials.gov